FIELD: medicine.
SUBSTANCE: method involves the stage of the recovery of genomic DNA from a clinical sample, the amplification of ACE, APOA4, APOA5, APOB, EDN1, MEF2A, FGA, ADRB1, TNBS4, APOE, FBN1, AGXT, MTHFR, CCR2, F5, F2, F7, ABCA1, ITGB3, AGTR2, B2R, DES, TLR4, NOS3, KDR, MMP9, THBS2, LPL, MPO gene sites containing sequences of polymorphic loci listed in SEQ ID 1-672 and the preparation of a one-chained fluorescent marked product by nick translation and restriction. A biochip applied for screening of predisposition to cardiovascular diseases and containing an immobilised oligonucleotide kit SEQ ID 1-672 is prepared. It is followed by hybridisation of the marked amplified product on said biochip. The results are recorded at wave length 635 nm and 532 nm for dyes Cy5 and Cy3 respectively. The hybridisation results are interpreted by comparing the intensity of fluorescent signals received after perfect and imperfect hybridisation.
EFFECT: invention allows producing an integrated assessment of patient's genetic predispositions to cardiovascular diseases and evaluating a risk of developing cardiovascular diseases.
6 cl, 29 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SCREENING CARDIOVASCULAR DISEASES AND BIOCHIP FOR SAID METHOD REALISATION | 2008 |
|
RU2402771C2 |
METHOD FOR DETECTING EARLY PHYSIOLOGICAL CARDIAC MALFUNCTION IN CHILDREN IN CONDITIONS OF CONTAMINATION WITH PHENOL | 2017 |
|
RU2657821C1 |
METHOD FOR ANALYSIS OF GENETIC POLYMORPHYSM, DEFINING PREDISPOSITION TO TUMOR DISEASES AND INDIVIDUAL SENSITIVITY TO PHARMACEUTICAL AGENTS BY USING OLYGONUCLEOTIDE BIOLOGICAL MICROARRAY (BIOARRAY) | 2005 |
|
RU2303634C2 |
METHOD OF SCREENING NEWBORNS FOR MONOGENIC DISEASES AND BIOCHIP FOR SAID METHOD REALISATION | 2008 |
|
RU2402612C2 |
METHOD OF ANALYZING POLYMORPHIC MARKERS IN THE GENES VKORC1, CYP4F2, CYP2C9, CYP2C19, ABCB1, ITGB3 TO DETERMINE INDIVIDUAL SENSITIVITY TO ANTICOAGULANT DRUGS | 2018 |
|
RU2689400C1 |
METHOD FOR CARDIOVASCULAR SYSTEM SCREENSING | 2018 |
|
RU2685683C1 |
METHOD FOR DETERMINATION OF INDIVIDUAL GENETIC RISK FOR ISCHEMIC STROKE | 2014 |
|
RU2612630C2 |
METHOD OF POLYMORPHIC MARKERS ANALYSIS IN THE GENES OF METABOLISM OF MEDICINAL PREPARATIONS AND THE GENES OF IMMUNE RESPONSE IN THE ACUTE LEUCOSISES THERAPY IN CHILDREN | 2016 |
|
RU2643333C1 |
METHOD FOR GENETIC POLYMORPHISM RAPID ANALYSIS FOR DETECTION OF GENETIC PREDISPOSITION TO BREAST CANCER | 2014 |
|
RU2617936C2 |
METHOD FOR ANALYSING GENETIC POLYMORPHISM FOR DETERMINING DISPOSITION TO SCHIZOPHRENIA AND ALCOHOLISM | 2012 |
|
RU2565036C2 |
Authors
Dates
2012-06-20—Published
2010-07-16—Filed